➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
McKesson
Colorcon
Baxter

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for The California Institute of Technology v. Broadcom Limited (C.D. Cal. 2016)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

The California Institute of Technology v. Broadcom Limited (C.D. Cal. 2016)

Docket   Start Trial Date Filed 2016-05-26
Court District Court, C.D. California Date Terminated
Cause 35:271 Patent Infringement Assigned To George H. Wu
Jury Demand Both Referred To Alicia G. Rosenberg
Parties AVAGO TECHNOLOGIES LIMITED; BROADCOM LIMITED; CYPRESS SEMICONDUCTOR CORPORATION; THE CALIFORNIA INSTITUTE OF TECHNOLOGY
Patents 10,000,547; 10,004,694; 10,004,746; 10,004,807; 10,005,783; 10,005,833; 10,005,954; 10,011,660; 10,018,638; 10,023,872; 10,028,858; 10,028,912; 10,034,872; 10,040,783; 10,040,872; 10,058,589; 10,065,947; 10,081,673; 10,085,955; 10,085,983; 10,093,609; 10,093,728; 10,097,388; 10,098,892; 10,098,970; 10,112,947; 10,116,969; 10,117,892; 10,117,951; 10,118,869; 10,118,961; 10,119,947; 10,130,626; 10,130,640; 10,131,907; 10,143,731; 10,143,755; 10,145,855; 10,179,816; 10,183,786; 10,186,816; 10,201,561; 10,201,584; 10,201,595; 10,206,918; 10,206,930; 10,213,393; 10,213,425; 10,213,513; 10,238,633; 10,238,640; 10,238,656; 10,238,725; 10,238,746; 10,238,951; 10,246,513; 10,261,083; 10,292,939; 10,292,951; 10,314,855; 10,314,899; 10,350,213; 10,364,466; 10,391,298; 10,421,954; 10,443,100; 10,457,711; 10,466,246; 10,517,865; 10,517,882; 10,555,939; 10,561,670; 10,563,179; 10,584,178; 10,584,350; 10,588,983; 10,589,001; 10,609,929; 6,001,964; 6,030,961; 6,032,954; 6,048,964; 6,053,827; 6,083,907; 6,183,969; 6,207,858; 6,238,657; 6,238,922; 6,284,711; 6,419,230; 6,461,163; 6,517,847; 6,561,930; 6,582,711; 6,582,728; 6,589,955; 6,589,960; 6,626,997; 6,638,547; 6,649,781; 6,673,574; 6,673,755; 6,673,802; 6,702,997; 6,710,165; 6,746,093; 6,773,960; 6,786,922; 6,827,926; 6,827,955; 6,830,520; 6,837,907; 6,855,353; 6,858,199; 6,858,584; 6,858,650; 6,858,664; 6,869,399; 6,869,939; 6,872,728; 6,891,085; 6,899,648; 6,899,717; 6,900,261; 6,906,081; 6,916,802; 6,926,907; 6,930,093; 6,930,119; 6,930,127; 6,933,146; 6,951,655; 6,953,120; 6,953,673; 6,956,027; 6,960,346; 6,960,561; 6,969,330; 6,983,876; 6,989,138; 6,989,146; 7,032,921; 7,048,926; 7,056,655; 7,056,890; 7,057,721; 7,067,461; 7,083,964; 7,101,574; 7,101,882; 7,115,640; 7,128,933; 7,131,916; 7,131,918; 7,132,554; 7,157,466; 7,179,461; 7,179,816; 7,182,717; 7,182,956; 7,182,961; 7,186,399; 7,186,561; 7,198,801; 7,198,950; 7,207,907; 7,225,584; 7,238,786; 7,238,855; 7,244,563; 7,261,900; 7,285,572; 7,285,668; 7,285,702; 7,288,657; 7,388,364; 7,393,533; 7,399,242; 7,419,983; 7,419,996; 7,443,135; 7,510,584; 7,517,292; 7,517,900; 7,517,964; 7,547,554; 7,572,198; 7,572,966; 7,582,694; 7,589,102; 7,638,620; 7,648,141; 7,648,702; 7,648,960; 7,655,038; 7,655,466; 7,655,630; 7,655,633; 7,655,833; 7,670,773; 7,678,242; 7,678,399; 7,718,609; 7,718,783; 7,728,118; 7,728,143; 7,728,191; 7,731,648; 7,731,989; 7,758,876; 7,758,890; 7,758,891; 7,786,118; 7,786,133; 7,786,273; 7,786,288; 7,790,954; 7,807,135; 7,807,208; 7,807,364; 7,807,717; 7,833,148; 7,851,179; 7,851,504; 7,858,118; 7,858,139; 7,892,116; 7,892,547; 7,892,563; 7,902,237; 7,902,388; 7,906,137; 7,906,283; 7,907,135; 7,939,288; 7,947,272; 7,947,711; 7,947,725; 7,950,353; 7,951,131; 7,951,133; 7,951,238; 7,951,589; 7,951,781; 7,951,786; 7,955,809; 7,956,067; 7,956,198; 7,956,246; 7,960,597; 7,964,183; 7,964,212; 7,964,402; 7,964,567; 7,964,580; 7,964,592; 7,964,648; 7,988,961; 8,012,694; 8,017,582; 8,017,758; 8,021,660; 8,026,393; 8,029,783; 8,030,457; 8,048,872; 8,051,851; 8,067,668; 8,083,620; 8,084,466; 8,097,648; 8,097,655; 8,101,582; 8,112,609; 8,114,969; 8,118,802; 8,119,648; 8,128,589; 8,128,933; 8,133,970; 8,137,728; 8,143,425; 8,147,461; 8,147,561; 8,147,852; 8,148,333; 8,148,399; 8,163,399; 8,163,725; 8,168,655; 8,178,554; 8,178,563; 8,178,664; 8,198,292; 8,206,735; 8,206,944; 8,206,951; 8,211,656; 8,211,872; 8,226,504; 8,226,996; 8,246,950; 8,246,953; 8,246,989; 8,261,833; 8,273,711; 8,273,721; 8,273,892; 8,273,950; 8,288,085; 8,298,554; 8,333,961; 8,388,907; 8,388,954; 8,399,640; 8,425,353; 8,461,085; 8,461,101; 8,461,137; 8,461,142; 8,461,178; 8,466,035; 8,466,137; 8,466,340; 8,512,983; 8,513,183; 8,545,830; 8,563,269; 8,563,513; 8,574,626; 8,574,855; 8,574,858; 8,589,114; 8,589,182; 8,595,165; 8,609,089; 8,609,095; 8,609,113; 8,609,137; 8,609,142; 8,609,432; 8,609,673; 8,609,831; 8,633,148; 8,633,178; 8,633,194; 8,633,201; 8,648,038; 8,648,048; 8,648,093; 8,648,095; 8,648,098; 8,668,083; 8,668,746; 8,668,914; 8,668,929; 8,673,547; 8,673,574; 8,673,582; 8,673,921; 8,673,923; 8,673,939; 8,673,964; 8,697,044; 8,697,067; 8,697,182; 8,697,711; 8,735,350; 8,735,574; 8,735,640; 8,746,242; 8,758,292; 8,778,340; 8,778,393; 8,778,916; 8,778,947; 8,790,655; 8,790,882; 8,795,657; 8,802,137; 8,802,152; 8,802,702; 8,802,717; 8,802,735; 8,802,816; 8,802,922; 8,807,861; 8,809,269; 8,809,388; 8,809,563; 8,828,956; 8,833,048; 8,852,032; 8,852,033; 8,852,036; 8,852,630; 8,858,961; 8,858,964; 8,858,996; 8,865,211; 8,865,461; 8,865,869; 8,865,954; 8,876,891; 8,894,987; 8,900,333; 8,900,582; 8,900,589; 8,900,638; 8,906,851; 8,906,876; 8,906,890; 8,906,954; 8,906,959; 8,907,065; 8,912,148; 8,916,131; 8,916,134; 8,916,141; 8,916,148; 8,916,206; 8,916,350; 8,916,616; 8,921,047; 8,921,393; 8,926,953; 8,933,051; 8,933,097; 8,933,120; 8,933,127; 8,933,191; 8,933,298; 8,951,504; 8,951,513; 8,951,790; 8,951,969; 8,951,996; 8,956,288; 8,956,830; 8,961,340; 8,961,997; 8,966,664; 8,969,008; 8,969,024; 8,969,388; 8,987,237; 8,987,292; 8,987,421; 8,987,457; 9,002,656; 9,005,964; 9,011,905; 9,011,926; 9,023,783; 9,023,807; 9,034,902; 9,034,951; 9,051,368; 9,051,582; 9,053,914; 9,067,989; 9,073,933; 9,073,988; 9,078,827; 9,079,953; 9,081,237; 9,084,728; 9,084,802; 9,085,620; 9,090,664; 9,101,660; 9,113,649; 9,114,451; 9,119,554; 9,119,781; 9,119,827; 9,131,929; 9,133,461; 9,139,649; 9,139,657; 9,179,899; 9,186,563; 9,198,595; 9,198,858; 9,198,869; 9,198,882; 9,198,892; 9,198,953; 9,198,954; 9,198,966; 9,199,983; 9,226,892; 9,226,961; 9,226,983; 9,238,657; 9,238,673; 9,238,678; 9,238,728; 9,238,731; 9,242,930; 9,284,515; 9,284,572; 9,314,461; 9,364,504; 9,364,656; 9,388,097; 9,388,425; 9,393,208; 9,393,213; 9,393,237; 9,393,238; 9,421,333; 9,451,914; 9,457,019; 9,457,020; 9,457,021; 9,457,027; 9,457,036; 9,457,065; 9,504,655; 9,504,660; 9,504,673; 9,504,697; 9,504,891; 9,517,023; 9,533,044; 9,533,102; 9,533,955; 9,545,399; 9,554,574; 9,561,208; 9,561,244; 9,561,417; 9,574,237; 9,630,930; 9,638,697; 9,642,816; 9,642,822; 9,649,284; 9,649,547; 9,650,393; 9,650,589; 9,650,640; 9,655,892; 9,655,907; 9,655,956; 9,656,954; 9,668,912; 9,694,015; 9,694,025; 9,694,100; 9,711,146; 9,717,237; 9,717,648; 9,717,852; 9,731,179; 9,731,869; 9,758,589; 9,782,657; 9,802,012; 9,802,095; 9,802,951; 9,807,432; 9,827,178; 9,827,191; 9,827,242; 9,850,969; 9,855,246; 9,855,284; 9,855,388; 9,872,837; 9,872,906; 9,890,147; 9,907,230; 9,907,802; 9,914,802; 9,914,951; 9,918,786; 9,918,950; 9,926,261; 9,926,561; 9,933,432; 9,944,711; 9,951,010; 9,951,112; 9,951,119; 9,951,138; 9,951,368; 9,961,916; 9,964,545; 9,969,668; 9,969,786; 9,970,059; 9,983,185; 9,983,213; 9,987,261; 9,987,330; 9,988,432; 9,995,746
Attorneys Aaron Shawn Thompson; Andrew S DeCarlow; Brian P Biddinger; Brian W Nolan; Charles McLean Stiernberg , Jr; Cliff Allan Maier; Deepa Acharya; Derek L Shaffer; Duane David Hough; Edward J DeFranco; Elizabeth D Mann; Elspeth V Hansen; Heather Elizabeth Belville; James L Quarles , III; James M Dowd; James R Asperger; Jason Francis Choy; Jordan R Jaffe; Joseph J Mueller; Kevin P B Johnson; Lance L Yang; Margaret Hsiao-Shia Shyr; Mark D Selwyn; Mary V Sooter; Michael Hal Smith; Michael J Malecek; Ognjen Zivojnovic; Peter E Root; Rachael Lynn Ballard McCracken; Richard A Goldenberg; Ron Hagiz; Seung Woo Hur; Todd M Briggs; Valerie Roddy; Victoria F Maroulis; William C Price; Zhaoxin Yin
Firms Elspeth v Hansen; Mayer Brown LLP; Quinn Emanuel Urquhart & Sullivan LLP; Quinn Emanuel Urquhart & Sullivan, LLP; Quinn Emanuel Urquhart and Sullivan LLP; Quinn Emanuel Urquhart and Sullivan, LLP; Wilmer Cutler Pickering Hale & Dorr LLP; Wilmer Cutler Pickering Hale and Dorr LLP; Wilmer, Cutler, Pickering, Hale & Dorr, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in The California Institute of Technology v. Broadcom Limited
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in The California Institute of Technology v. Broadcom Limited

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for The California Institute of Technology v. Broadcom Limited (C.D. Cal. 2016)

Date Filed Document No. Description Snippet Link To Document
2020-04-06 2165 Permanent Injunction chips infringed the patents-in-suit. 19 After the case was filed, Apple filed ten inter partes review…U.S. at 655 n. 10 (a prejudgment interest award should not 9 “undercompensates the patent owner”, thereby…January 29, 2020, Defendants have 10 continued to infringe Caltech’s patents by selling the accused products… decisions 10 determining that the asserted references were not material to patentability. Yet 11 Defendants… same outcome 10 as to the ’710 and ’032 Patents”). After multiple rounds of briefing, the Court 11 External link to document
2020-04-07 2167 chips infringed the patents-in-suit. 19 After the case was filed, Apple filed ten inter partes review…. at 655 n. 10 (a prejudgment interest award should not 9 “undercompensates the patent owner”, thereby…January 29, 2020, Defendants have 10 continued to infringe Caltech’s patents by selling the accused products…decisions 10 determining that the asserted references were not material to patentability. Yet 11 Defendants… same outcome 10 as to the ’710 and ’032 Patents”). After multiple rounds of briefing, the Court 11 External link to document
2020-05-01 2179 Response in Opposition to Motion responding to 7 Caltech’s subpoena. Dkt. 1470 at 65:10-18, 67:1-21, 69:5-70:24. Caltech’s motion 8 …that the 9 [asserted] patent was valid and was being infringed”).12 10 Third, Caltech attempts…raised … in an IPR petition” (and, thus, the Patent Office 10 had never addressed its disclosure or materiality… Laitram Corp. v. NEC Corp., 9 115 F.3d 947 (Fed. Cir. 1997) ................................…infringement.” Laitram Corp. v. NEC Corp., 115 14 F.3d 947, 955 (Fed. Cir. 1997); Mars, 513 F. Supp. 2d at 136 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Colorcon
Merck
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.